beth israel deaconess medical center a harvard medical school teaching hospital

To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Health Headlines

BIDHC-Chestnut Hill is Now Open

Beth Israel Deaconess Medical Center’s new, comprehensive outpatient center in Chestnut Hill Square officially opened to patients on July 15, 2014.

beth israel deacones healthcare facility at chestnut hill Beth Israel Deaconess HealthCare-Chestnut Hill, located in the square’s rear building above Wegmans, fills an entire floor with a range of services, including primary care, sports medicine and rehabilitation, obstetrics and gynecology, integrative medicine, and multiple medical and surgical specialties.

Also housed in the new facility is a laboratory for blood drawing and a radiology suite that includes CT scan and screening mammography.

Advanced urgent care — for non-life threatening illness or injury that needs immediate attention — will also be available to anyone ages 3 months and up beginning August 4. Beth Israel Deaconess Urgent Care at Chestnut Hill will be open seven days a week, with extended evening hours and no appointment necessary. All patients in the Urgent Care center will be seen by a physician board-certified in emergency medicine.

The new Center for Sports Medicine and Rehabilitation at Chestnut Hill is another highlight, offering treatment for a full spectrum of athletic injuries and musculoskeletal problems and conditions. Doctors and rehabilitation specialists work together to help athletes — both recreational and competitive — heal and return to their activities as quickly and as safely as possible.

BIDHC-Chestnut Hill, along with similar outpatient facilities in Chelsea and Lexington, is just one more way for BIDMC to offer patients the convenience of our world-class medical care closer to home.

Learn more at

Cancer Center Launches Institute for RNA Medicine

The Cancer Center at Beth Israel Deaconess Medical Center has launched a new research institute to harness the potential of RNA to revolutionize the way cancer and ultimately other diseases are treated and diagnosed.

Frank Slack, PhD, Director of the new Institute for RNA Medicine at BIDMC's Cancer CenterThe Institute for RNA Medicine (iRM), established under the leadership of renowned cancer geneticist and BIDMC Cancer Center Director Pier Paolo Pandolfi, MD, PhD, will bring together leading investigators in the field to pursue new lines of inquiry into non-coding RNA, a highly promising area of research that significantly expands the known boundaries of the human genome.

“Although the sequencing of the human genome marked a critical era in molecular biology, it has become clear that this was only the beginning of the story,” says Pandolfi. “Scientific research over the past decade has concentrated almost exclusively on the two percent of the genome’s protein coding regions, ignoring the other 98 percent, a vast universe of non-coding genetic material previously dismissed as nothing more than ‘junk.’ It is now apparent that these non-coding RNAs contain a wealth of crucial clues to both health and disease that will guide us in our quest to understand the mysteries of cancer and to develop therapies to cure this deadly disease.”

The iRM will capitalize on BIDMC’s large, growing and varied patient population, as well as its unique mouse modeling facility and streamlined co-clinical trial platform, to bring non-coding RNA laboratory discoveries into the clinical setting.

Distinguished Scientist Named Director

Molecular biologist Frank Slack, PhD (pictured above), an international leader in the study and understanding of microRNAs, a subset of non-coding RNA, has been named director of the iRM. Slack will join co-founders Pandolfi and trailblazing molecular biologist John Rinn, PhD, in launching the iRM, thus bringing together three visionary leaders whose scientific breakthroughs have helped form the foundation for this dynamic field.

“Frank Slack’s research played an important role in shifting the scientific view of non-coding RNA from one of insignificance to a promising source of personalized diagnostics and therapies,” says Jeffrey Saffitz, MD, PhD, Chairman of Pathology at BIDMC and another iRM co-founder. “Dr. Slack’s discoveries into the roles played by microRNAs in regulating human disease genes have already revealed key insights into oncogenic and tumor suppression functions and have enabled us to move past the discovery stage and into the translational phase of this rapidly growing field.”

Slack will move his laboratory to the iRM’s new location in the Center for Life Sciences building in the Longwood Medical Area, adjacent to BIDMC. He has been a member of the Yale University faculty since 2000, most recently as a Professor of Molecular, Cellular and Developmental Biology and Director of the Yale Center for RNA Science and Medicine. He holds a doctorate in molecular biology from Tufts University School of Medicine and completed post-doctoral training at Stanford University School of Medicine and Harvard University.

“Beth Israel Deaconess Medical Center is recognized around the world for the novel discoveries in long non-coding RNAs (lincRNAs) and ceRNAs made by Drs. Pandolfi and Rinn,” says Slack. “Our non-coding RNA investigations complement one another and create the opportunity for the emergence of exciting synergies. Cancer takes numerous forms in many different tissues, but the disease is ultimately driven by cells that grow out of control. Non-coding RNAs are playing an integral role in this process and have revealed themselves to be great novel targets of anti-cancer therapies.” 
Read more about the new iRM at BIDMC »

NBC Nightly News Features Brain Fit Club

Beth Israel Deaconess Medical Center’s Brain Fit Club was recently featured as part of an NBC Nightly News story about a new study on Alzheimer’s disease.

The study, from the Karolinska Institutet in Sweden and the National Institute for Health and Welfare in Helsinki, Finland, looked at 1,260 individuals, aged 60 to 77, who were deemed to be at risk for Alzheimer's disease. They were randomly assigned to either a group who received lifestyle interventions, or a group that received general health advice. The two groups were tested for cognitive function before the study began and again at the end of two years. 

At the end of two years, the group who received interventions like those available in BIDMC's Brain Fit Club, including exercise, nutrition, sleep evaluation and memory training, scored 40 percent higher on memory tests than the group who did not receive these interventions.

Watch the NBC Nightly News story »

Learn more about BIDMC's Brain Fit Club »

Above content provided by Beth Israel Deaconess Medical Center. For advice about your medical care, consult your doctor. 

July 2014

Contact Information

Beth Israel Deaconess Medical Center
330 Brookline Avenue, Boston, MA 02215
Main Switchboard: 617-667-7000
Find a Doctor: 800-667-5356
Directions by Phone: 617-667-3000
TDD (for hearing impaired): 800-439-0183